Teva Saw Record Growth In 2008 Across Key Businesses
This article was originally published in The Pink Sheet Daily
Executive Summary
In contrast to Big Pharma’s doldrums, generics manufacturer Teva had a banner year in 2008 – and expects a strong follow up in 2009.